News Search

Category: Schools

PCI and PACT Host AI Event for Philly Tech Week 

PCI and the Philadelphia Alliance for Capital and Technologies (PACT) jointly presented a recent event called “AI Nexus: Shaping Tomorrow’s Intelligence."

A Rare Patient Mutation May Help Lead to More Effective Treatments for Genetic Bone Disease 

Davis' relatively benign symptomology is attributed to low levels of the inflammatory protein MMP-9, which seems to prevent the characteristic abnormal bone formation.

Penn Engineering’s Deep Jariwala and Troy Olsson Develop Heat-resistant Memory Device that can Withstand Extreme Temperatures 

This device, whose heat tolerance far surpasses existing commercial storage technologies, could help to facilitate computing under extreme conditions like deep-earth drilling and space missions.

Penn Researchers Create Novel mRNA-based Avian Flu Vaccine 

Penn Medicine researchers have developed an mRNA vaccine for the H5N1 avian flu using techniques similar to those enabling mRNA-based COVID-19 vaccines.

EU Approves Expanded Use of Sobi’s Aspaveli® for Rare Blood Disorder 

The European Commission has approved Sobi's drug Aspaveli® (pegcetacoplan) for broader use in adults with paroxysmal nocturnal hemoglobinuria (PNH), a rare blood disorder.

Exyn Technologies Partners with Measur to Expand Canadian Footprint 

Measur plans to bring Exyn's cutting-edge technologies like the Nexys 3D SLAM LiDAR payload system to market.

Carisma Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of CT-0525, Appoints Eugene P. Kennedy as Chief Medical Officer  

Carisma announced the dosing of its first patient in its Phase 1 trial for CT-0525, an innovative CAR-Monocyte therapy targeting HER2-overexpressing solid tumors.

Verismo Therapeutics Receives FDA Clearance for Phase I Trial of its CAR-T Therapy 

Penn spinout Verismo Therapeutics has received FDA clearance for a Phase I trial of its CAR-T therapy, SynKIR-310.

iEcure Receives Three FDA Designations for its In Vivo Gene Insertion Program 

iEcure, a gene-editing company spun out of Penn and co-founded by Dr. Wilson, has received three special designations from the FDA for its new treatment, ECUR-506.

New Technology Video: An Inside Look at Marc Miskin’s New Technology for Reflective Displays  

The invention consists of an array of individually addressable microscale optical resonators and arrangements of optical components which allow a beam of light to circulate more efficiently.


Skip to content